Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
Comprehensive development strategy yields two potential drugs that block cancer-promoting pathways

Comprehensive development strategy yields two potential drugs that block cancer-promoting pathways

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study

Study: Elderly people with untreated visual disorders more likely to develop Alzheimer's disease

Study: Elderly people with untreated visual disorders more likely to develop Alzheimer's disease

Phase 2 study results: VEGF Trap-Eye improves vision in patients with DME

Phase 2 study results: VEGF Trap-Eye improves vision in patients with DME

Diabetic retinopathy: 5.3M U.S adults suffer

Diabetic retinopathy: 5.3M U.S adults suffer

Scientists uncover new gene that could help save sight of patients with inherited blindness

Scientists uncover new gene that could help save sight of patients with inherited blindness

Thrombogenics announces publication of positive microplasmin Phase II trial results

Thrombogenics announces publication of positive microplasmin Phase II trial results

Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529

Paloma Pharmaceuticals receives FDA approval to enter Phase I studies with P529

MSU scientist discovers the process that causes retinal cells to die

MSU scientist discovers the process that causes retinal cells to die

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

Congressional leader stresses the importance of annual dilated eye exam for diabetes patients

Redwood Consultants to assist DMI Life Sciences in shareholder relations and investor communications

Redwood Consultants to assist DMI Life Sciences in shareholder relations and investor communications

Social inequalities exist in diabetes care

Social inequalities exist in diabetes care

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy

6th Annual Diabetes Conference to feature ocular drug delivery in diabetic retinopathy

Breakthrough discovery could lead to new treatments for a variety of CNS disorders

Breakthrough discovery could lead to new treatments for a variety of CNS disorders

Researchers discover potential treatment for blinding disease

Researchers discover potential treatment for blinding disease

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy

Highlights of January 2010 'Ophthalmology'

Highlights of January 2010 'Ophthalmology'

Steroids not superior to laser treatments for DME

Steroids not superior to laser treatments for DME

Positive results from Alimera Sciences' Iluvien FAME trial for DME

Positive results from Alimera Sciences' Iluvien FAME trial for DME

Comprehensive up-date on pharmacology-assisted vitreoretinal surgery

Comprehensive up-date on pharmacology-assisted vitreoretinal surgery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.